Williams DC - Search Results

1

The novel pyrrolo-1,5-benzoxazepine, PBOX-15, synergistically enhances the apoptotic efficacy of imatinib in gastrointestinal stromal tumours; suggested mechanism of action of PBOX-15.

Kinsella P, Greene LM, Bright SA, Pollock JK, Butini S, Campiani G, Bauer S, Williams DC, Zisterer DM. Kinsella P, et al. Among authors: williams dc. Invest New Drugs. 2016 Apr;34(2):159-67. doi: 10.1007/s10637-016-0331-1. Epub 2016 Feb 17. Invest New Drugs. 2016. PMID: 26885657

2

The effects of the peripheral-type benzodiazepine acceptor ligands, Ro 5-4864 and PK 11195, on mitochondrial respiration.

Zisterer DM, Gorman AM, Williams DC, Murphy MP. Zisterer DM, et al. Among authors: williams dc. Methods Find Exp Clin Pharmacol. 1992 Mar;14(2):85-90. Methods Find Exp Clin Pharmacol. 1992. PMID: 1317932

3

PK 11195 reduces the brain availability of lindane in rats and the convulsions induced by this neurotoxic agent.

Zisterer DM, Suñol C, Moynagh PN, Williams DC, Rodríguez-Farré E. Zisterer DM, et al. Among authors: williams dc. Life Sci. 1995;57(25):2359-64. doi: 10.1016/0024-3205(95)02230-g. Life Sci. 1995. PMID: 7491094

4

Identification of novel ligands for the peripheral-type benzodiazepine receptor.

Zisterer DM, Williams DC. Zisterer DM, et al. Among authors: williams dc. Biochem Soc Trans. 1995 May;23(2):371S. doi: 10.1042/bst023371s. Biochem Soc Trans. 1995. PMID: 7672402 No abstract available.

5

Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific "peripheral-type" benzodiazepine receptor ligands.

Campiani G, Nacci V, Fiorini I, De Filippis MP, Garofalo A, Ciani SM, Greco G, Novellino E, Williams DC, Zisterer DM, Woods MJ, Mihai C, Manzoni C, Mennini T. Campiani G, et al. Among authors: williams dc. J Med Chem. 1996 Aug 30;39(18):3435-50. doi: 10.1021/jm960251b. J Med Chem. 1996. PMID: 8784441

6

Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver.

Woods MJ, Zisterer DM, Williams DC. Woods MJ, et al. Among authors: williams dc. Biochem Pharmacol. 1996 May 17;51(10):1283-92. doi: 10.1016/0006-2952(96)00034-2. Biochem Pharmacol. 1996. PMID: 8787543

7

Hexachlorocyclohexanes inhibit steroidogenesis in Y1 cells. Absence of correlation with binding to the peripheral-type benzodiazepine binding site.

Zisterer DM, Moynagh PN, Williams DC. Zisterer DM, et al. Among authors: williams dc. Biochem Pharmacol. 1996 May 17;51(10):1303-8. doi: 10.1016/0006-2952(96)00036-6. Biochem Pharmacol. 1996. PMID: 8787545

8

Calmidazolium and other imidazole compounds affect steroidogenesis in Y1 cells: lack of involvement of the peripheral-type benzodiazepine receptor.

Zisterer DM, Williams DC. Zisterer DM, et al. Among authors: williams dc. J Steroid Biochem Mol Biol. 1997 Feb;60(3-4):189-95. doi: 10.1016/s0960-0760(96)00189-6. J Steroid Biochem Mol Biol. 1997. PMID: 9191976

9

Peripheral-type benzodiazepine receptors.

Zisterer DM, Williams DC. Zisterer DM, et al. Among authors: williams dc. Gen Pharmacol. 1997 Sep;29(3):305-14. doi: 10.1016/s0306-3623(96)00473-9. Gen Pharmacol. 1997. PMID: 9378234 Review.

10

Antiproliferative action of pyrrolobenzoxazepine derivatives in cultured cells: absence of correlation with binding to the peripheral-type benzodiazepine binding site.

Zisterer DM, Hance N, Campiani G, Garofalo A, Nacci V, Williams DC. Zisterer DM, et al. Among authors: williams dc. Biochem Pharmacol. 1998 Feb 15;55(4):397-403. doi: 10.1016/s0006-2952(97)00500-5. Biochem Pharmacol. 1998. PMID: 9514073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

740 results

Search Page